Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $952.37B | 34.5x | 1.31 | $37.14 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $59.43B | 28.1x | 3.97 | $200 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.8% Downside | Upgrade to Pro+ | |
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $31.09B | 24x | $20.51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $31.09B | 24x | -2.74 | $21.90 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $31.09B | 24x | $239 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $31.09B | 24x | -2.74 | $24.24 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $31.09B | 24x | -2.74 | $21.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $31.09B | 24x | -2.74 | $242.75 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $21.37B | 22.6x | -10.77 | $97.48 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2% Downside | Upgrade to Pro+ | |
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $10.79B | 16.4x | -2.33 | $46.67 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $2.40B | 18.3x | 12.61 | $50.57 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.3% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $1.69B | 23.8x | 0.16 | $7.14 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $357.63M | -19.9x | -0.24 | $5.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $251.27M | -0.6x | 0 | $0.75 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $199.92M | -30.6x | -0.37 | $2.47 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $170.58M | -1.6x | -0.07 | $0.49 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $170.58M | -1.6x | -0.07 | $0.49 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $163.92M | -34.1x | -1.76 | $2.65 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.2% Upside | Upgrade to Pro+ | |
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $100.03M | -1.3x | -0.02 | $0.25 | -21.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $97.55M | -1.1x | -0.02 | $0.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | $91.81M | 46x | -0.81 | $0.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $56.28M | -30x | 0.83 | $0.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $45.05M | -2.7x | -0.1 | $0.12 | -20.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $38.93M | -0.7x | -0.03 | $0.007 | 50% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C21 Invest | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $23.60M | $0.20 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $19.22M | -2x | -0.08 | $0.69 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Flora | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | $15.52M | -0.1x | 0 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $13.23M | -11.6x | -0.19 | $0.09 | -58.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanadaBis Capital | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $12.44M | 65.1x | -0.69 | $0.09 | -5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nass Valley Gateway | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $11.62M | -7.5x | $0.04 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $6.64M | -0.8x | -0.02 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Im Cannabis | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $5.75M | -0.4x | 0.48 | $2.20 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rocky Mountain Liquor | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $5.50M | -11x | 0.07 | $0.12 | 15% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueberries Medical | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $4.95M | -4.7x | -0.09 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | $4.94M | -0.8x | -0.02 | $0.03 | -37.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ORAGIN Foods | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $3.12M | -1x | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Entourage Health | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $1.54M | -0x | -0 | $0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astron Connect | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $756.78K | -4.9x | -0.1 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kiaro Holdings | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | $221.07K | -0x | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |